Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Plant-made pharmaceuticals].

L Faye1, P Lerouge, V Gomord

  • 1CNRS UMR 6037-IFRMP23-Université de Rouen, F76821 Mont St Aignan, France.

Annales Pharmaceutiques Francaises
|April 2, 2003
PubMed
Summary

Transgenic plants offer a scalable solution for producing antibody molecules to meet rising immunotherapy demands. This research explores their potential for large-scale antibody production and processing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Step Towards the Humanisation of Protein N-Glycosylation in Chlamydomonas reinhardtii Through Heterologous Expression of α(1,2)-Mannosidases.

Plant biotechnology journal·2025
Same author

Glycomolecules: from "sweet immunity" to "sweet biostimulation"?

Physiologia plantarum·2024
Same author

Fine-tuning the N-glycosylation of recombinant human erythropoietin using Chlamydomonas reinhardtii mutants.

Plant biotechnology journal·2024
Same author

Plant-based enveloped Ara h 2 bioparticles display exceptional hypo-allergenicity.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2023
Same author

Management of work-related common mental disorders in general practice: a cross-sectional study.

BMC family practice·2020
Same author

Prevalence of work-related common psychiatric disorders in primary care: The French Héraclès study.

Psychiatry research·2017

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Context:

  • Antibodies are crucial for diagnostics and therapeutics.
  • Immunotherapy has seen a rise in approved monoclonal antibody treatments.
  • Increased demand for antibody molecules necessitates scalable production methods.

Purpose:

  • To explore transgenic plants as a system for large-scale antibody production.
  • To evaluate the potential of plants in antibody manufacturing.
  • To address the growing need for antibody molecules in medicine.

Summary:

  • This paper focuses on transgenic plants as a viable system for the large-scale production and processing of antibody molecules.
  • It highlights the increasing demand for antibodies driven by advancements in immunotherapy.
  • Alternative production systems, particularly transgenic plants, are investigated to meet this demand.

Impact:

  • Potential to significantly increase antibody production capacity.
  • Offers a cost-effective and scalable manufacturing platform.
  • Could accelerate the development and accessibility of antibody-based therapies.

Related Experiment Videos